Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: Clues from long-term follow-up

Europace

Volumn 10, Issue 7, 2008, Pages 816-820

  Peters, Stefan ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Ajmaline challenge; Arrhythmogenic right ventricular cardiomyopathy; Brugada phenomenon; Conduction disease; Molecular genetics

Indexed keywords

AJMALICINE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; CLINICAL EXAMINATION; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; PROVOCATION TEST; SCN5A GENE; ST SEGMENT ELEVATION; SYNCOPE;

ADULT; AGE FACTORS; AJMALINE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; PACEMAKER, ARTIFICIAL; SEX FACTORS; SODIUM CHANNELS; TREATMENT OUTCOME;

EID: 45849106060     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun030     Document Type: Article

References (20)

1. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989;118:1203-9.
2. Tada H, Aihara N, Ohe T, Yutani C, Hamada S, Miyanuma H et al. Arrhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation and sudden death. Am J Cardiol 1998;81:519-22.
3. Izumi T, Ajiki K, Nozaki A, Takahashi S, Tabei F, Hayakawa H et al. Right ventricular cardiomyopathy showing right bundle branch block and right precordial ST segment elevation. Intern Med 2000;39:28-33.
4. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001;103:710-7.
5. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquires sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol 2007;293:H2024-38.
6. Tukkie R, Sogaard P, Vleugels J, de Groot IK, Wilde AA, Tan HL. Delay in right ventricular activation contributes to Brugada syndrome. Circulation 2004;109:1272-7.
7. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005;112:2769-77.
8. Peters S, Trümmel M, Denecke S, Koehler B. Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasiacardiomyopathy. Int J Cardiol 2004;95:207-10.
9. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G et al. Task force of the working group myocardial and pericardial disease and the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Diagnosis of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Br Heart J 1994;71:215-8.
10. Peters S. Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int J Cardiol 2006;113:4-11.
11. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-24.
12. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
13. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D et al. Cicumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-5.
14. Gronda M, Rognoni G, D'Aulerio M, Occhetta E, Rossi P. Prognostic evaluation of infranodal conduction abnormalities by ajmaline and overdriving test (author's transl). G Ital Cardiol 1980;10:1594-604.
15. David D, Cabanis C, Guize L, Le Heuzey JY, Carcone P, Née M et al. Clinical and electrophysiological aspects of median intra-His bundle block with normal electrocardiogram at rest. Arch Ma Coeur Vaiss 1985;78:1009-18.
16. Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K et al. The ajmaline challenge in Brugada syndrome: diagnostiv impact, safety, and recommended protocol. Eur Heart J 2003;24:1104-12.
17. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada sindrome caused by SCN5A mutations. Circulation 2004;110:3023-7.
18. Chiale PA, Przybylski J, Laino RA, Halpern MS, Sanchez RA, Gabrieli A et al. Electrocardiographic changes evoked by ajmaline in chronic chagas disease without manifest myocarditis. Am J Cardiol 1982;49:14-20.
19. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005;112:3680-7.
20. Peters S, Trümmel M, Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol 2004;97:499-501.